Thomas Marron

Medical Oncology · Icahn School of Medicine at Mount Sinai

Credentials: · · · · ·

History

Breaking the Myeloid-Stromal Axis to Treat Colorectal Cancer
National Cancer Institute · R01
Contact PI · $697.1K · Icahn School of Medicine at Mount Sinai
2026–2031
Type 2 Immunity: A Primitive Response to Epithelial Injury That Shapes Bone Marrow and Lung Myeloid Crosstalk
National Cancer Institute · R01
PI · $2.6M · Icahn School of Medicine at Mount Sinai
2023–2028

A Study of Exercise and Pharmacologic Intervention on Systemic Inflammation
Principal investigator · Active not recruiting · Phase 1
Icahn School of Medicine at Mount Sinai
2025–2027
Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC
Principal investigator · Recruiting · Phase 1, Phase 2
Icahn School of Medicine at Mount Sinai
2024–2027
Lamivudine for Solid Tumors
Principal investigator · Active not recruiting · Phase 1, Phase 2
Thomas Marron
2024–2027
Dupilumab_Metastatic NSCLC
Principal investigator · Active not recruiting · Phase 1, Phase 2
Thomas Marron
2021–2030